BMJ Oncology Journal Citation Rate 2026
2752-7948
BMJ
Q1 Quartile Open Access Established Impact
About BMJ Oncology
BMJ Oncology (BO) is a peer-reviewed academic journal covering Cancer Immunotherapy and Biomarkers and Economic and Financial Impacts of Cancer, published by BMJ, catalogued under ISSN 2752-7948. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 4.52 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access. OpenAlex records 233 works and 1,473 citations, with an h-index of 16.
Authors typically receive a first decision in around 113 days.
BMJ Oncology Citation Rate 2026 — In Context
BMJ Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 4.52, placing it in the Q1 quartile within the Cancer Immunotherapy and Biomarkers research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, BMJ Oncology makes all articles freely available to readers. Average submission-to-decision turnaround is approximately 113 days.
Researchers looking to publish in BMJ Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare BMJ Oncology against similar journals in the field, use our journal comparison tool.
Submission Tips for BMJ Oncology
- Be prepared for a longer review cycle — decisions typically take around 113 days.
- This journal covers Cancer Immunotherapy and Biomarkers, Economic and Financial Impacts of Cancer, Genetic factors in colorectal cancer. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How BMJ Oncology Compares
Compared against 49 journals in the same research areas.
| ISSN (Print) | 2752-7948 |
|---|---|
| Publisher | BMJ |
| APC / Cost | Inquire with Publisher |
| Review Speed | ~113 days to first decision |
In-depth profile & metrics
BMJ Oncology is published by BMJ. It publishes on an open-access basis.
In our subject taxonomy, BMJ Oncology is classified under Cancer Immunotherapy and Biomarkers, Economic and Financial Impacts of Cancer, Genetic factors in colorectal cancer and Global Cancer Incidence and Screening.
For prospective authors, BMJ Oncology returns a first decision in about 113 days (longer for its field).
Its most recent citation rate stands at 4.516.
Research Areas
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about BMJ Oncology
Live Indexing Status
Updated May 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 4.516 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Journal Metrics
Compare Journals
Compare BMJ Oncology against similar publications in its field:
Related Journals in Your Field
-
Cancer Cell Elsevier IF 64.50
-
Journal for ImmunoTherapy of Cancer BMJ IF 7.57
-
PLoS Medicine Public Library of Science IF 7.20
-
Journal of Translational Medicine BioMed Central IF 6.81
-
Modern Pathology Elsevier BV IF 5.84
Explore More Journals
Metadata
Last updated: May 21, 2026
Updated by: system
Get weekly updates for Cancer Immunotherapy and Biomarkers journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.